Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Researchers in France and Luxembourg have developed an AI model that creates a "digital twin" for patients with type 1 diabetes, mapping their individual risk for serious complications. Using data from over 2,000 patients, the tool identifies seven distinct clinical phenotypes — from well-controlled disease to very high cardiovascular or renal risk. The goal: help clinicians personalize prevention and treatment strategies in real time.
Researchers in France and Luxembourg are developing a digital twin model for patients with type 1 diabetes (T1D) — an AI-driven tool that maps each person's unique risk profile for serious complications like kidney disease and cardiovascular events. Drawing on data from 2,187 participants in the SFDT1 cohort (one of the world's largest T1D datasets), the model uses 25 variables — including glucose monitoring data, lab values, lifestyle factors, and sociodemographic information — to place patients on a seven-branch "tree" of clinical phenotypes.
The tool isn't meant to replace existing risk scores but to act as a simulation engine. Clinicians could ask: What happens to this patient's renal risk if their A1c drops by 1%? What if they lose 5 kg? Patients, too, could visualize how lifestyle changes shift their risk profile — making it a powerful educational tool alongside its clinical utility.
Key Takeaways:
Why it matters: For the millions of people worldwide living with T1D, complications remain a leading cause of morbidity. A validated, real-time simulation tool could shift diabetes care from reactive to truly preventive — giving both clinicians and patients a clearer roadmap for long-term health.